Industry Briefs: Mar. 12, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Amgen has completed its tender offer for the outstanding shares of Micromet.
Celgene has completed its acquisition of Avila Therapeutics.
EMD Millipore and the Centre for Commercialization of Regenerative Medicine have agreed to develop optimized conditions for bioreactor-based cultivation of stem cells.
Marken plans to open four additional logistics branches in India.
Mylan plans to build a new corporate headquarters near its current location in the Southpointe Office Park located in Cecil Township, Pennsylvania.
SCM Pharma invests in an expansion of its vial-filling capabilities.
Valeant Pharmaceuticals has agreed to acquire certain assets from Gerot Lannach.
Valeant Pharmaceuticals has acquired a 19.9% minority equity investment in Pele Nova Biotecnologia.
People News
Catalent Pharma Solutions has named Jeremie Trochu to the newly created position of vice-president of commercial excellence, effective immediately.
Hovione has appointed Colin Minchom as vice-president of its particle-design business unit.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
